Teva Pharmaceutical Industries Limited (TEV) — Capital Reinvestment Ratio
Teva Pharmaceutical Industries Limited (TEV) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow (€1.16 Billion) in capital expenditures (€142.00 Million). See TEV free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Teva Pharmaceutical Industries Limited Capital Reinvestment Ratio (2015–2025)
This chart tracks Teva Pharmaceutical Industries Limited's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year Capital Reinvestment Ratio for Teva Pharmaceutical Industries Limited from 2015 to 2025. For live market cap and broader valuation context, see Teva Pharmaceutical Industries Limited market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | €1.65 Billion | €501.00 Million | ▼ -23.9% |
| 2024 | 0.40x | €1.25 Billion | €498.00 Million | ▼ -15.8% |
| 2023 | 0.47x | €1.16 Billion | €549.00 Million | ▲ +37.7% |
| 2022 | 0.34x | €1.59 Billion | €548.00 Million | ▼ -51.1% |
| 2021 | 0.70x | €798.00 Million | €562.00 Million | ▲ +48.2% |
| 2020 | 0.48x | €1.22 Billion | €578.00 Million | ▼ -32.3% |
| 2019 | 0.70x | €748.00 Million | €525.00 Million | ▲ +163.7% |
| 2018 | 0.27x | €2.45 Billion | €651.00 Million | ▼ -32.2% |
| 2017 | 0.39x | €2.23 Billion | €874.00 Million | ▲ +69.6% |
| 2016 | 0.23x | €3.89 Billion | €901.00 Million | ▲ +66.3% |
| 2015 | 0.14x | €5.54 Billion | €772.00 Million | — |